CaaMTech
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $22M
Investors
- 1
About CaaMTech
Based in Washington, US, and founded in 2019, CaaMTech, Inc. develops and optimizes psychedelic compounds to build a patent portfolio. The company was founded by Dr. Andrew Chadeayne who was also a Chief Innovations Officer at ebb, Inc. The company's platform focused on engineering psychedelic drugs. It has produced an extensive library of novel, analytically pure compounds that are nearing advancement into human trials. CaaMTech, Inc. uses the latest laboratory and computational technologies to drive the research and development of novel psychedelic drugs.
Who invested in CaaMTech
1 investor across 1 round
See all investors in CaaMTech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 8, 2021
Amount
$22M
Investors
Questions about CaaMTech
Who invested in CaaMTech?
CaaMTech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CaaMTech raised?
CaaMTech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CaaMTech last raise money?
CaaMTech's most recent round on record is a Series A, in Sep 2021.
What does CaaMTech do?
Based in Washington, US, and founded in 2019, CaaMTech, Inc.
Where is CaaMTech headquartered?
CaaMTech is headquartered in Issaquah, US.
Which VCs invest in companies like CaaMTech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at CaaMTech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like CaaMTech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.